GAD1 and type 1 diabetes mellitus: Although autoantibodies to GAD67 are detected in approximately 60–70% of T1D patients, they typically result from cross-reactivity with GAD65 due to high inter-isoenzyme homology, thus defining GAD67 as a minor autoantigen [51].